Abstract: Methods and apparatuses control electrical current supplied to a plurality of processing units in a multi-processor system. A plurality of current usage information corresponding to the processing units are received by a controller to determine a threshold current for each of the processing units. The controller determines a frequency reduction action and an instructions-per-cycle (IPC) reduction action for the each of the processing units based on the threshold current and regulates operations of the processing units based on the determined frequency and IPC reduction actions.

Abstract: Automated migration systems and methods are described for generating guided user interfaces (GUIs) for tracking migrating legacy networked resources within a computer network environment during a technical migration. The automated migration systems and methods include loading, by a dashboard tracking application (app) implemented on a migration server according to first and second migration schema formats, into a migration database each of first and second reporting data and first and second tracking data corresponding to first and second legacy networked resources as tracked during an active migration session. The dashboard tracking app receives, during the active migration session, a dashboard request for graphical status of each of the first and second legacy networked resources, and automatically generates a tracking GUI rendering first and second statutes of the first and second legacy networked resources based on the first and second reporting data and the first and second tracking data.

Abstract: The present disclosure relates to protein hydrolysate based biostimulant composition derived from methanotrophic bacteria, and methods for enhancing agricultural productivity. In particular, the compositions disclosed herein comprise a protein-derived component in an amount of about 30% or less with respect to weight of the composition, wherein said protein-derived component is obtained from a methanotrophic bacterium. The present biostimulant composition finds applications in methods for improving plant performance along with methods for reducing the need of external chemical fertilizer-based inputs for plant growth.

Abstract: Automated migration systems and methods are described for generating guided user interfaces (GUIs) for tracking migrating legacy networked resources within a computer network environment during a technical migration. The automated migration systems and methods include loading, by a dashboard tracking application (app) implemented on a migration server according to first and second migration schema formats, into a migration database each of first and second reporting data and first and second tracking data corresponding to first and second legacy networked resources as tracked during an active migration session. The dashboard tracking app receives, during the active migration session, a dashboard request for graphical status of each of the first and second legacy networked resources, and automatically generates a tracking GUI rendering first and second statutes of the first and second legacy networked resources based on the first and second reporting data and the first and second tracking data.

Abstract: Methods and apparatuses control electrical current supplied to a plurality of processing units in a multi-processor system. A plurality of current usage information corresponding to the processing units are received by a controller to determine a threshold current for each of the processing units. The controller determines a frequency reduction action and an instructions-per-cycle (IPC) reduction action for the each of the processing units based on the threshold current and regulates operations of the processing units based on the determined frequency and IPC reduction actions.

Abstract: Methods and systems for facilitating improved power consumption control of a plurality of processing cores are disclosed. The methods improve the power consumption control by performing power throttling based on a determined excess power consumption. The methods include the steps of: monitoring using at least one event count component in the respective processing core a plurality of distributed events; calculating an accumulated weighted sum of the distributed events from the event count component; determining an excess power consumption by comparing the accumulated weighted sum with a threshold power value; and adjusting power consumption of the respective processing core based on the determined excess power consumption.

Abstract: Methods and apparatuses control electrical current supplied to a plurality of processing units in a multi-processor system. A plurality of current usage information corresponding to the processing units are received by a controller to determine a threshold current for each of the processing units. The controller determines a frequency reduction action and an instructions-per-cycle (IPC) reduction action for the each of the processing units based on the threshold current and regulates operations of the processing units based on the determined frequency and IPC reduction actions.

Abstract: Compounds and compositions useful for the treatment of liver diseases and methods of treating liver diseases are disclosed. The compounds of the invention specifically interact with heteromers of cannabinoid receptors as compared to monomers or homodimers. The invention also relates to methods of screening for compounds useful for the treatment of liver diseases and to methods of screening for diacylglycerol lipase inhibitors.

Abstract: The present disclosure is related to a process comprising steps of fermentation, separation and purification that can be carried out in a centralized facility with large scale fermentation or in a decentralized facility with smaller scales of fermentation to make value added products from substrate not limiting to gaseous substrates effectively. The fermentation involves fermentative production of a marketable product using reactors or fermentors which are optimized for influential parameters such as gaseous substrate, gas hold up, mass transfer coefficient, etc. The separation step involves an effective way of separating desired product from fermentation broth by employing filtration, precipitation or adsorption techniques thereby enabling easy transportation of the product in case of a decentralized facility. The final stage of the process, either in centralized or decentralized facility, includes the elution of retained product and further purification of the same using downstream processing techniques.

Abstract: Compounds and compositions useful for the treatment of liver diseases and methods of treating liver diseases are disclosed. The compounds of the invention specifically interact with heteromers of cannabinoid receptors as compared to monomers or homodimers. The invention also relates to methods of screening for compounds useful for the treatment of liver diseases and to methods of screening for diacylglycerol lipase inhibitors.

Abstract: The present disclosure is related to a process comprising steps of fermentation, separation and purification that can be carried out in a centralized facility with large scale fermentation or in a decentralized facility with smaller scales of fermentation to make value added products from substrate not limiting to gaseous substrates effectively. The fermentation involves fermentative production of a marketable product using reactors or fermentors which are optimized for influential parameters such as gaseous substrate, gas hold up, mass transfer coefficient, etc. The separation step involves an effective way of separating desired product from fermentation broth by employing filtration, precipitation or adsorption techniques thereby enabling easy transportation of the product in case of a decentralized facility. The final stage of the process, either in centralized or decentralized facility, includes the elution of retained product and further purification of the same using downstream processing techniques.

Abstract: Compounds and compositions useful for the treatment of liver diseases and methods of treating liver diseases are disclosed. The compounds of the invention specifically interact with heteromers of cannabinoid receptors as compared to monomers or homodimers. The invention also relates to methods of screening for compounds useful for the treatment of liver diseases and to methods of screening for diacylglycerol lipase inhibitors.

Abstract: Compounds and compositions useful for the treatment of liver diseases and methods of treating liver diseases are disclosed. The compounds of the invention specifically interact with heteromers of cannabinoid receptors as compared to monomers or homodimers. The invention also relates to methods of screening for compounds useful for the treatment of liver diseases and to methods of screening for diacylglycerol lipase inhibitors.

Abstract: The present invention refers to a pharmaceutical composition that includes an active ingredient, such as a peptide, which acts as an antagonist and/or inverse agonist of a G protein-coupled receptor and pharmaceutically acceptable vehicle. The pharmaceutical composition may be used for the treatment of obesity and the prevention of and the treatment of diabetes.

Abstract: Compounds and compositions useful for the treatment of liver diseases and methods of treating liver diseases are disclosed. The compounds of the invention specifically interact with heteromers of cannabinoid receptors as compared to monomers or homodimers. The invention also relates to methods of screening for compounds useful for the treatment of liver diseases and to methods of screening for diacylglycerol lipase inhibitors.

Abstract: Compounds and compositions useful for the treatment of liver diseases and methods of treating liver diseases are disclosed. The compounds of the invention specifically interact with heteromers of cannabinoid receptors as compared to monomers or homodimers. The invention also relates to methods of screening for compounds useful for the treatment of liver diseases and to methods of screening for diacylglycerol lipase inhibitors.

Abstract: The present invention refers to a pharmaceutical composition that comprises an active ingredient, such as a peptide, which acts as an antagonist and/or inverse agonist of a G protein-coupled receptor and pharmaceutically acceptable vehicle. Said pharmaceutical composition may be used for the treatment of obesity and the prevention of and the treatment of diabetes.

Abstract: A method, executed by a processor, for automatically integrating tracks into a software build receives a track to be integrated and determines if all tracks dependent upon the received track have been integrated into the software build. If all tracks dependent upon the received tracks are determined to have been integrated, the method automatically creates build scripts according the received track. If not all tracks dependent upon the received tracks are determined to have been integrated, the method notifies owners of the received track and any unintegrated dependent tracks. The method automatically starts build processes according to the build scripts. If all the build processes are successful, the method marks the received track and all the dependent tracks as good and ready for a product build.

Abstract: The present invention refers to a pharmaceutical compositions that comprises an active ingredient, such as a peptide, which acts as an antagonist and/or inverse agonist of a G protein-coupled receptor and pharmaceutically acceptable vehicle.

Abstract: Compounds and compositions useful for the treatment of liver diseases and methods of treating liver diseases are disclosed. The compounds of the invention specifically interact with heteromers of cannabinoid receptors as compared to monomers or homodimers. The invention also relates to methods of screening for compounds useful for the treatment of liver diseases and to methods of screening for diacylglycerol lipase inhibitors.